Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cirdan

Explore full profile

Leading provider of informatics software and imaging solutions that enhance and speed up the diagnosis of patients.

Lisburn, United KingdomFounded 2010Health Tech & Medtech
Valuation $25–50M Last recorded · 2025
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cirdan and the history behind them.

About Cirdan

Cirdan is a medical devices company focused on revolutionizing laboratories worldwide with advanced diagnostic solutions. The company offers streamlined, scalable, and automated systems that enhance clinical pathways through real-time data analysis and AI tools. Cirdan's tailored solutions cover the entire clinical pathway, optimizing patient diagnosis and boosting workflow efficiency. The company's primary product, the ULTRA Laboratory Information System (LIS), is designed to meet the needs of clinicians, scientists, pathologists, administrators, and patients. Cirdan serves a global clientele, including over 100 successful LIS installations and partnerships with 80 national laboratories. The business model revolves around providing comprehensive laboratory solutions and continuous support, ensuring expertise and assistance are always accessible. Cirdan also offers a digital pathology education platform, Cirdan Tutor, and imaging solutions for breast biopsy, surgery, and pathology. The company generates revenue through the sale and support of its diagnostic systems and educational platforms.

Source: Dealroom company data

At a glance

Founded
2010
Headquarters
Lisburn, United Kingdom
Sector
Health Tech & Medtech

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Kernel Capital
  • QUBIS
  • Clarendon Fund Managers
  • Kainos
  • 57 Stars
  • British Business Bank

Series B and later1 investor entered at this stage

  • Salica Investments
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇬🇧 United Kingdom74.4%
🇦🇺 Australia11.1%
🇨🇦 Canada4.4%
🇵🇹 Portugal4.4%
🇮🇪 Ireland2.2%
Top 5 of 7 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cirdan on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cirdan on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.